Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446).
JOURNAL OF CLINICAL ONCOLOGY(2022)
关键词
thyroid,cancer,etctn9446,wild-type,radioiodine-refractory
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要